stars 1 stars 2 stars 3

QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases. QLT's head office is based in Vancouver, Canada and the company is publicly traded on NASDAQ (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT). For more information, visit our website at www.qltinc.com.

QLT Inc. Questions

The QLT Inc. annual revenue was $138.4 million in 2026.

Alexander Lussow is the Senior Vice President, Business Development and Commercial Operations of QLT Inc..

27 people are employed at QLT Inc..

QLT Inc. is based in Vancouver, British Columbia.

The NAICS codes for QLT Inc. are [325412, 32541, 541, 54, 325, 3254, 32].

The SIC codes for QLT Inc. are [283, 73, 737, 28].

Top QLT Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users